Lataa...
Novel Therapies in Phase II and III Trials for Malignant Pleural Mesothelioma
Mesothelioma is a rare malignancy of the pleura with limited therapeutic options. Despite the desperate need to develop better treatment for this disease, the rarity of the tumor type creates formidable challenges in clinical research. Nonetheless, several novel agents are under investigation. Most...
Tallennettuna:
| Julkaisussa: | J Natl Compr Canc Netw |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2012
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4343316/ https://ncbi.nlm.nih.gov/pubmed/22223868 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|